Skip to main content

AMERICAN BIO MEDICA CORP Value Stock - Dividend - Research Selection

AMERICAN BIO MEDICA CORP

ISIN: US0246001087, WKN: 912562

Market price date: 05.08.2020
Market price: 0,55 USD




AMERICAN BIO MEDICA CORP Fundamental data and company key figures of the share

Annual reports in USD
Key figures 29-06-2020
Cash flow
Net operating cash flow 58.000
Capital Expenditures -1
Free cash flow 57.999
Balance sheet
Total Equity -790.000
Liabilities & Shareholders equity 2.078.000
Income statement
Net income -681.000
Eps (diluted) -0,020
Diluted shares outstanding 34.050.000
Net sales/revenue 3.655.000

Fundamental ratios calculated on: 05-08-2020

Ratios
Key figures 05-08-2020
Cash flow
P/C 322,89
   
P/FC 322,89
Balance sheet
ROI-32,77
ROE-38,02
Income statement
P/E-27,50
Div. Yield0,00%
P/B-23,71
P/S5,12


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolABMC
Market Capitalization15.322.500,00 USD
CountryUnited States
IndicesNASDAQ Comp.
SectorsBiotechnology
Raw Data SourceUS GAAP in Millionen USD
Stock Split
Internetwww.abmc.com


Description of the company

American Bio Medica Corporation develops, manufactures, and sells lateral flow immunoassay tests for the immediate detection of drugs in urine and oral fluids at the point of collection. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test that detects the presence or absence of 2 to 10 drugs; Rapid ONE product line that consists of single drug tests, each of which tests for the presence or absence of a single drug; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform that detects the presence or absence of 2 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 14 drugs, as well as private labeled versions of Rapid TOX. The company also offers OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions OralStat. Its tests detect various drugs, such as amphetamines, barbiturates, benzodiazepines, buprenorphine, cocaine, MDMA, methadone, methamphetamines, opiates, oxycodone, phencyclidine, propoxyphene, marijuana, and tricyclic antidepressants. In addition, the company distributes other products for the detection of substances of abuse comprising Rapid Reader, a compact, portable unit that uses a high-resolution camera to capture a picture of the results obtained when using an ABMC drug-testing product; and products that detect the presence or absence of adulterants and alcohol. Further, it provides bulk test strip contract manufacturing services to non-affiliated diagnostic companies. The company serves rehabilitation/drug treatment, pain management, other clinical, government and employment/workplace markets in the United States and internationally. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was founded in 1986 and is based in Kinderhook, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.abmc.com